Development of Real-Time Quantitative Polymerase Chain Reaction Assays to Track Treatment Response in Retinoid Resistant Acute Promyelocytic Leukemia

Molecular detection of minimal residual disease (MRD) has become established to assess remission status and guide therapy in patients with ProMyelocytic Leukemia–RARA+ acute promyelocytic leukemia (APL). However, there are few data on tracking disease response in patients with rarer retinoid resista...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Jovanovic, Jelena V., Rennie, Kristian, Culligan, Dominic, Peniket, Andrew, Lennard, Anne, Harrison, Justin, Vyas, Paresh, Grimwade, David
Materialtyp: Artigo
Språk:Inglês
Publicerad: Frontiers Research Foundation 2011
Ämnen:
Oncology
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3356041/
https://ncbi.nlm.nih.gov/pubmed/22655241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2011.00035
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk